Hollingshead, Melinda
National Institutes of Health · National Cancer Institute · Center for Cancer Research
6 papers on CoChatORCID 0000-0002-1207-1397
Most cited papers
- Verified
The National Cancer Institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity
Holbeck, S. L., Camalier, R., Crowell, J. A., Govindharajulu, J. P., Hollingshead, M., Anderson, L. W., Polley, E., Rubinstein, L., Srivastava, A., Wilsker, D., et al. (2017) · Cancer Research
Computational Drug Discovery MethodsCancer Cells and Metastasis
Cited by 359
- Verified
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas
Kummar, S., Chen, A., Ji, J., Zhang, Y., Reid, J. M., Ames, M., Jia, L., Weil, M., Speranza, G., Murgo, A. J., et al. (2011) · Cancer Research
PARP inhibition in cancer therapyCancer therapeutics and mechanisms
Cited by 259
- Verified
Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts
Rapisarda, A., Zalek, J., Hollingshead, M., Braunschweig, T., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Hewitt, S. M., Shoemaker, R. H., et al. (2004) · Cancer Research
Cancer, Hypoxia, and MetabolismCancer therapeutics and mechanisms
Cited by 187
- Verified
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
Rapisarda, A., Hollingshead, M., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Gehrs, B., Raffeld, M., Kinders, R. J., Parchment, R., et al. (2009) · Molecular Cancer Therapeutics
Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer
Cited by 171
- Verified
Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas
Chang, L.-S., Oblinger, J. L., Burns, S. S., Huang, J., Anderson, L. W., Hollingshead, M. G., Shen, R., Pan, L., Agarwal, G., Ren, Y., et al. (2020) · Molecular Cancer Therapeutics
PI3K/AKT/mTOR signaling in cancerRNA and protein synthesis mechanisms
Cited by 22
- Verified · note
Abstract 3616: Validation and fitness testing of a quantitative immunoassay for HIF1α in biopsy specimens
Park, S. R., Kinders, R. J., Khin, S., Hollingshead, M., Parchment, R. E., Tomaszewski, J. E., & Doroshow, J. H. (2012) · Cancer Research
Cancer, Hypoxia, and MetabolismClinical Laboratory Practices and Quality Control
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free